Latest NEUVENGE Stories
SYDNEY, May 27, 2014 /PRNewswire/ -- Novogen Limited (NASDAQ: NVGN, ASX:NRT), an oncology drug development company, today announced that it has achieved a key milestone with
MARINA DEL REY, Calif., April 23, 2014 /PRNewswire/ -- Join Prostate Oncology Specialists for an educational talk about PROVENGE - a treatment to stimulate the immune system for advanced prostate
Personalized immunotherapy vaccine developed by Perseus PCI offers breakthrough, non-toxic treatment for cancer patients that uses the body's own cells to attack tumors and turn off the engine
- The act of sweetening by admixture of some saccharine substance.